{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T01:35:17Z","timestamp":1769391317066,"version":"3.49.0"},"reference-count":29,"publisher":"Georg Thieme Verlag KG","issue":"07","license":[{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Neuropsiquiatr"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Background\u2003The Hammersmith Functional Motor Scale Expanded (HFMSE) has been widely used to assess the motor function of patients with spinal muscular atrophy (SMA) older than 2 years, with the ability to sit and\/or walk.<\/jats:p><jats:p>\n          Objective\u2003To translate, cross-culturally adapt and validate the HFMSE to Brazilian Portuguese.<\/jats:p><jats:p>\n          Methods\u2003The translation process and cross-cultural adaptation followed international guidelines recommendations. The reliability and applicability of the Brazilian version consisted of the application of the HFMSE (in Brazilian Portuguese) to 20 patients with types 2 and 3 SMA. Two examiners assessed the participants for interrater reliability, through the analysis of Kappa reliability agreement (k) and intraclass correlation coefficient (ICC).<\/jats:p><jats:p>\n          Results\u2003The HFMSE was successfully translated and cross culturally adapted to Brazilian Portuguese. Twenty participants with types 2 and 3 SMA were enrolled in the study (type 2\u2009=\u20096; type 3\u2009=\u200914). The ICC for the total score showed very high reliability (ICC =1.00), and the reliability of each of the items individually was considered excellent (Kappa\u2009&gt;\u20090.80).<\/jats:p><jats:p>\n          Conclusion\u2003The Brazilian version of the HFMSE proved to be valid and reliable for the evaluation of SMA patients older than 2 years with the ability to sit and\/or walk.<\/jats:p>","DOI":"10.1055\/s-0044-1788587","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:45:25Z","timestamp":1722300325000},"page":"001-007","source":"Crossref","is-referenced-by-count":3,"title":["Brazilian version of the Hammersmith Functional Motor Scale Expanded: cross-cultural adaptation and validation"],"prefix":"10.1055","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9058-602X","authenticated-orcid":false,"given":"Ana Carolina Monteiro Lessa de","family":"Moura","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Departamento de Pediatria, Belo Horizonte MG, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2115-5768","authenticated-orcid":false,"given":"Marina Belis\u00e1rio","family":"Carvalhais","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Departamento de Pediatria, Belo Horizonte MG, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5962-2195","authenticated-orcid":false,"given":"Gabriela Palhares Campolina","family":"Sampaio","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Departamento de Pediatria, Belo Horizonte MG, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8416-1180","authenticated-orcid":false,"given":"Clara Catharino","family":"Pinhati","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Departamento de Pediatria, Belo Horizonte MG, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7357-0819","authenticated-orcid":false,"given":"Jacqueline","family":"Montes","sequence":"additional","affiliation":[{"name":"Columbia University Irving Medical Center, Department of Rehabilitation and Regenerative Medicine, New York, United States."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3335-1491","authenticated-orcid":false,"given":"Juliana","family":"Gurgel-Giannetti","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Departamento de Pediatria, Belo Horizonte MG, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,7,29]]},"reference":[{"issue":"03","key":"ref1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/ana.24864","article-title":"Emerging therapies and challenges in spinal muscular atrophy","volume":"81","author":"M A Farrar","year":"2017","journal-title":"Ann Neurol"},{"issue":"01","key":"ref2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"S Lefebvre","year":"1995","journal-title":"Cell"},{"issue":"01","key":"ref3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-022-00380-8","article-title":"Spinal muscular atrophy","volume":"8","author":"E Mercuri","year":"2022","journal-title":"Nat Rev Dis Primers"},{"issue":"02","key":"ref4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/acn3.51281","article-title":"Natural history of Type 2 and 3 spinal muscular atrophy: 2-year NatHis-SMA study","volume":"8","author":"M Annoussamy","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"issue":"18","key":"ref5","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1212\/WNL.0b013e318271f7e4","article-title":"Prospective cohort study of spinal muscular atrophy types 2 and 3","volume":"79","author":"P Kaufmann","year":"2012","journal-title":"Neurology"},{"issue":"10","key":"ref6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.nmd.2017.05.011","article-title":"Spinal muscular atrophy: A changing phenotype beyond the clinical trials","volume":"27","author":"E F Tizzano","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"07","key":"ref7","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.nmd.2008.05.005","article-title":"Outcome measure for SMA II and III patients","volume":"18","author":"C B\u00e9rard","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1016\/S0929-693X(20)30276-1","article-title":"State of the art for motor function assessment tools in spinal muscular atrophy (SMA)","volume":"27","author":"C Vuillerot","year":"2020","journal-title":"Arch Pediatr"},{"issue":"09","key":"ref9","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1001\/archneur.59.9.1445","article-title":"Outcome measures for pediatric spinal muscular atrophy","volume":"59","author":"S T Iannaccone","year":"2002","journal-title":"Arch Neurol"},{"issue":"02","key":"ref10","doi-asserted-by":"publisher","first-page":"e0172346","DOI":"10.1371\/journal.pone.0172346","article-title":"Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment tool","volume":"12","author":"D Ramsey","year":"2017","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpn.2022.04.006","article-title":"Mid- and long-term (at least 12 months) follow-up of patients with spinal muscular atrophy (SMA) treated with nusinersen, onasemnogene abeparvovec, risdiplam or combination therapies: A systematic review of real-world study data","volume":"39","author":"J Erdos","year":"2022","journal-title":"Eur J Paediatr Neurol"},{"issue":"04","key":"ref12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/s1090-3798(03)00060-6","article-title":"The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation","volume":"7","author":"M Main","year":"2003","journal-title":"Eur J Paediatr Neurol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.nmd.2007.05.009","article-title":"An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients","volume":"17","author":"J M O'Hagen","year":"2007","journal-title":"Neuromuscul Disord"},{"issue":"02","key":"ref14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care","volume":"28","author":"E Mercuri","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"01","key":"ref15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12883-017-0790-9","article-title":"Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy","volume":"17","author":"M C Pera","year":"2017","journal-title":"BMC Neurol"},{"issue":"02","key":"ref16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.nmd.2005.11.010","article-title":"Reliability of the Hammersmith functional motor scale for spinal muscular atrophy in a multicentric study","volume":"16","author":"E Mercuri","year":"2006","journal-title":"Neuromuscul Disord"},{"issue":"24","key":"ref17","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1097\/00007632-200012150-00014","article-title":"Guidelines for the process of cross-cultural adaptation of self-report measures","volume":"25","author":"D E Beaton","year":"2000","journal-title":"Spine"},{"issue":"02","key":"ref18","first-page":"202","article-title":"Check list for healthcare questionnaires cross-cultural translation and adaptation","volume":"27","author":"C PDD Fortes","year":"2019","journal-title":"Cad Saude Colet"},{"issue":"12","key":"ref20","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1177\/0883073811420294","article-title":"Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and III","volume":"26","author":"A M Glanzman","year":"2011","journal-title":"J Child Neurol"},{"key":"ref21","volume-title":"Statistics Principles and Methods","author":"R Johnson","year":"1986"},{"key":"ref22","volume-title":"Practical Nonparametric Statistics,","author":"CONOVER","year":"1980"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1037\/1082-989X.1.1.30","article-title":"Forming inferences about some intraclass correlation coefficients","volume":"1","author":"K O McGraw","year":"1996","journal-title":"Psychol Methods"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2307\/2532052","article-title":"2\u2009\u00d7\u20092 kappa coefficients: measures of agreement or association","volume":"45","author":"D A Bloch","year":"1989","journal-title":"Biometrics"},{"issue":"04","key":"ref25","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/16501970510030156","article-title":"Physical complaints in ageing persons with spinal muscular atrophy","volume":"37","author":"I J de Groot","year":"2005","journal-title":"J Rehabil Med"},{"issue":"07","key":"ref26","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1710504","article-title":"Nusinersen versus sham control in later-onset spinal muscular atrophy","volume":"378","author":"E Mercuri","year":"2018","journal-title":"N Engl J Med"},{"issue":"07","key":"ref27","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1111\/ene.15499","article-title":"Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo-controlled, dose-finding trial followed by 24\u2009months of treatment","volume":"30","author":"E Mercuri","year":"2023","journal-title":"Eur J Neurol"},{"issue":"01","key":"ref28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13023-019-0998-4","article-title":"SMArtCARE - A platform to collect real-life outcome data of patients with spinal muscular atrophy","volume":"14","author":"A Pechmann","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"09","key":"ref29","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1055\/s-0043-177283230","article-title":"Brazilian version of the CHOP INTEND scale: cross-cultural adaptation and validation","volume":"81","author":"R MR Alves","year":"2023","journal-title":"Arq Neuropsiquiatr"},{"issue":"10","key":"ref30","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.3390\/jcm12103458","article-title":"Measuring Fatigue and Fatigability in Spinal Muscular Atrophy (SMA): Challenges and Opportunities","volume":"12","author":"R S Rodriguez-Torres","year":"2023","journal-title":"J Clin Med"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1788587.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T17:18:51Z","timestamp":1730827131000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1788587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":29,"journal-issue":{"issue":"07","published-online":{"date-parts":[[2024,5,13]]},"published-print":{"date-parts":[[2024,7]]}},"alternative-id":["s00441788587"],"URL":"https:\/\/doi.org\/10.1055\/s-0044-1788587","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0004-282X","1678-4227"],"issn-type":[{"value":"0004-282X","type":"print"},{"value":"1678-4227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}